AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
DocGo's revenue has collapsed, overshadowing its recent acquisition. Despite operational improvements in 2023, the company operates in a highly competitive, low-margin healthcare segment with unclear future prospects. Despite being cheap, it's still a hold due to its uncertain future.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet